Clinical Trials Browser

Phase 2 × INDUSTRY × zalutumumab × Clear all

NCT00460551 2011-12-06

Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer

Phase 2 Terminated

13 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung

NCT01449357 2011-10-10

Zalutumumab in Non-Small Cell Lung Cancer (NSCLC) Patients Refractory to Tyrosine Kinase Inhibitors

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung